Supplementary Data 1 from A Phase I Study of the CDK4/6 Inhibitor Palbociclib in Combination with Cetuximab and Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25011402.v1
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
186
Citations
6
h-index
5
i10-index
Lalida Arsa is an academic researcher from Ramathibodi Hospital. The author has contributed to research in topics: Lung Cancer Research Studies & Neuroendocrine Tumor Research Advances & Lung Cancer Treatments and Mutations. The author has an h-index of 6, co-authored 20 publications.
ORCID: 0000-0003-3475-2107https://doi.org/10.1158/1078-0432.25011402.v1
https://doi.org/10.1186/s13000-025-01725-z
Click to start Chat